Gedivumab, CAS [[1807954-17-1]]

Produktübersicht

• Artikelname: Gedivumab, CAS [[1807954-17-1]]
• Artikelnummer: TGM-T77021
• Hersteller Artikelnummer: T77021
• Alternativnummer: TGM-T77021-1MG,TGM-T77021-5MG,TGM-T77021-10MG,TGM-T77021-25MG,TGM-T77021-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MHAA 4549A , MHAA4549A , RG 7745 , RG7745

Produktbeschreibung

Gedivumab (MHAA4549A, RG7745) is a human monoclonal antibody that specifically targets influenza A virus by binding the highly conserved stem region of the viral haemagglutinin protein, Gedivumab prevents haemagglutinin maturation and blocking membrane fusion during viral entry within the intranucleosomal environment, and it is extensively applied in influenza A virus infection studies and antiviral therapeutic research.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1807954-17-1]
• Target-Kategorie: Influenza Virus